Company / Free Cash Flow per Share
Vanda Pharmaceuticals Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.21
FY2025
5-year range
$0.21 / $1.12
FY2021-FY2025
Trend
-60.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.92 in FY2016 to $1.12 in FY2023.
Based on SEC 10-K filings.
0.21 in FY2025 with a 5-year CAGR of -17.4%.
Declined from $1.12 to $0.21 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -38.0%
- 5-Year CAGR
- -17.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 60.9% year-over-year.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -60.9% |
| FY2024 | $0.54 | -51.5% |
| FY2023 | $1.12 | +25.4% |
| FY2022 | $0.89 | +9.2% |
| FY2021 | $0.82 | +48.1% |
| FY2020 | $0.55 | +895.9% |
| FY2019 | -$0.07 | +67.2% |
| FY2018 | -$0.21 | -193.8% |
| FY2017 | $0.23 | +111.7% |
| FY2016 | -$1.92 | -100.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026